Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-25

Clinical Trial Update: The SPACER Trial - Repair of Tricuspid Valve Regurgitation Using the Edwards TricuSPid TrAnsCatheter REpaiR System [NA]

View source ↗

Summary

Completed trial update for SPACER trial assessing Edwards TricuSPid TransCatheter Repair System in tricuspid valve regurgitation; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TricuSPid TransCatheter Repair System (null)

Snippet

Sponsor: Edwards Lifesciences | Conditions: Tricuspid Valve Regurgitation | NA | Status: COMPLETED | Results posted: 2022-10-25